Skip to main content
. 2018 Jul 11;45(13):2264–2273. doi: 10.1007/s00259-018-4083-3

Fig. 4.

Fig. 4

Overall survival in relation baseline alkaline phosphatase (ALPBL) status (normal in 16 patients, elevated in 40; one patient did not have any baseline data). Median survival times: 401 days in patients with normal ALPBL, and 222 days in those with elevated ALPBL. Median follow-up times: 468 days in patients with normal ALPBL, and 234 days in those with elevated ALPBL. ,. *p = 0.01 vs. normal ALPBL